ArticleThe Journal of infectious diseases2022

Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination.

Suvichada Assawakosri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.